Connectlife Pharma Private Limited

PRODUCT INTRODUCTIONMounjaro 7.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 7.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 7.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 7.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 7.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 7.5mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
USES OF MOUNJARO SOLUTION FOR INJECTION

To improve glycemic control in adults with Type 2 diabetes mellitus

Management of Obesity

BENEFITS OF MOUNJARO SOLUTION FOR INJECTIONIn To improve glycemic control in adults with Type 2 diabetes mellitusMounjaro 7.5mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.

Mounjaro 12.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 12.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 12.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 12.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 12.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 12.5mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms

Mounjaro 5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.
Mounjaro 5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.
Common side effects of Mounjaro 5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.
Mounjaro 5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 5mg KwikPen.
Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
USES OF MOUNJARO SOLUTION FOR INJECTION
To improve glycemic control in adults with Type 2 diabetes mellitus
Management of Obesity
BENEFITS OF MOUNJARO SOLUTION FOR INJECTIONIn To improve glycemic control in adults with Type 2 diabetes mellitusMounjaro 5mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.

PRODUCT INTRODUCTIONMounjaro 10mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 10mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 10mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 10mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 10mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 10mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
BENEFITS OF MOUNJARO SOLUTION FOR INJECTIONIn To improve glycemic control in adults with Type 2 diabetes mellitusMounjaro 10mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.

HOW MOUNJARO SOLUTION FOR INJECTION WORKSMounjaro 10mg KwikPen helps control blood sugar and support weight loss by imitating the effects of two natural hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) in your body. It helps your body release insulin when blood sugar is high and lowers the hormone that raises blood sugar. It also slows down the rate at which food leaves your stomach, so you feel full for longer and eat less. By acting on your brain to reduce hunger, this medicine helps you manage blood sugar better and lose weight more effectively than other medicines that target only one hormone.

PRODUCT INTRODUCTIONMounjaro 2.5mg kwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 2.5mg kwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 2.5mg kwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 2.5mg kwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 2.5mg kwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 2.5mg kwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
USES OF MOUNJARO SOLUTION FOR INJECTION

To improve glycemic control in adults with Type 2 diabetes mellitus

Management of Obesity